Discrimination and Tobacco Use in LGBTQ Young Adults

Apr.20.2023
Discrimination and Tobacco Use in LGBTQ Young Adults
Tobacco Control is an international journal that studies the effects of tobacco on health, economy, environment, and society.

Tobacco Control is an international journal aimed at studying the nature and consequences of tobacco use worldwide, including its impact on population health, the economy, the environment, and society. The journal seeks to prevent and control the widespread use of tobacco through promoting public knowledge of tobacco, industry ethics, policy-making, and social activism by the tobacco industry and its allies, playing a positive role in these areas. On December 7, 2022, the journal published a paper entitled "Discrimination, Identity Connectedness and Tobacco Use in a Sample of Sexual and Gender Minority Young Adults".


Source of image: The front page of the December 2022 issue of "Tobacco Control" journal, featuring an article on discrimination, identity affiliation, and smoking behavior among young adults in the LGBTQ community.


The summary of this paper can be translated into standard journalistic English as follows:


Title: Higher Tobacco Use Among Sexual and Gender Minority Populations According to previous research in academia, a widely accepted viewpoint is that sexual and gender minority (SGM) populations have higher smoking rates than heterosexual or cisgender populations. However, there is little research exploring the smoking habits of different racial/ethnic SGM subgroups or the association between SGM-specific discrimination and identity with smoking behavior. A new study in the United States has shown that SGM populations have higher tobacco use rates compared to heterosexual populations. The study also found differences in tobacco use rates among SGM subgroups based on ethnicity and identity.


The research team includes experts and scholars Alex Budenz, Jennifer Gaber, Erik Crankshaw, Andie Malterud, Emily B Peterson, Dana E Wagner, and Emily C Sanders. These individuals come from various organizations, including the Center for Tobacco Products in the Office of Health Communication and Education at the U.S. Food and Drug Administration, the Center for Health Analytics, Media and Policy at RTI International, and the Research Department at Rescue Agency.


Research methodology: This study surveyed 11,313 young American sexual and gender minority (SGM) adults to investigate the associations between different tobacco use methods (including traditional cigarettes, e-cigarettes, cigars, and tobacco powder) and SGM sub-populations, race/ethnicity, SGM-specific discrimination, and identity. Data analysis was conducted using multiple logistic regression models to predict the relationships between SGM sub-populations, race/ethnicity, SGM-specific discrimination, identity, and various tobacco use methods.


Investigation Results: The study revealed that there are differences in tobacco use among sub-groups of the sexual minority population and between different races/ethnicities. Female homosexuals (especially black female homosexuals) are more likely than average to use multiple tobacco products. White bisexuals and female homosexuals have a higher likelihood of smoking cigarettes and e-cigarettes than the average. Severe discrimination is associated with the use of multiple tobacco products, and the more likely SGM groups are to identify with discrimination and tobacco use being positively correlated, the more likely they are to defend their smoking behavior as being reasonable.


Conclusion: This study found differences in tobacco use among SGM subgroups and among different races/ethnicities. Experiencing discrimination may be a risk factor for tobacco use behavior, while a strong sense of SGM identity may provide an explanatory role for certain tobacco use behaviors among gender and sexual minorities and those experiencing specific SGM discrimination. These findings can guide targeted approaches to reach SGM subgroups at higher risk for tobacco use. The researchers call for the development of more comprehensive and precise policies and interventions to eliminate the inequality surrounding this public health issue.


Reference:


Discrimination, Identity Connections, and Tobacco Use Among Sexual and Gender Minority Young Adults: A Study


Related Reading:


【Science】Latest scientific research clarifies the link between nicotine addiction and human identity cognition.


A recent scientific experiment shows that the flavor of nicotine and marijuana-based electronic cigarette products is a factor in attracting more adolescents to try them.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23